In the 90 days prior to the date of this filing, there have been 15 insider transactions reported to the SEC for Alexion Pharmaceuticals. These transactions came from the activities of 14 different insiders that resulted in a net disposition of 276,418 company shares. In the preceding 90-day window of time, there were 26 transactions from 9 insiders and resulted in the net acquisition of 69,012 shares.
This is a lower level of transactions than the peer group average in the 55-company Biopharmaceuticals peer group over the last 90-day period. Peer group activity averaged 29.4 transactions per company, with company insiders acquiring on average 99,640 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/899866/000089986619000079/xslF345X03/wf-form4_156210004597380.xml
|2019 Estimate for United States Steel Raised but 202...|
|58.com's 2019 Estimate Scaled Up but Q3, and 2020 Pr...|
|2019, 2020, and Q3 Earnings Estimates for W&T Of...|
|Virtusa's 2020, 2021, and Q2 Earnings Estimates Lowered|
|2019 Estimate for Vornado Realty Trust Raised but 20...|